Parkinson's disease drug or medication, titration, delivery system, and method
AssigneeGreat Lakes NeuroTechnologies Inc.
InventorJoseph Giffrida
Life of this patent
Estimating the term…
Loading patent…
AssigneeGreat Lakes NeuroTechnologies Inc.
InventorJoseph Giffrida
Estimating the term…
The present invention relates to a movement disorder monitor, and a method of measuring the severity of a subject's movement disorder. The present invention additionally relates to a drug delivery system for dosing a subject in response to the increased severity of a subject's symptoms. The present invention provides for a system and method, which can accurately quantify symptoms of movements disorders, accurately quantifies symptoms utilizing both kinetic information and electromyography (EMG) data, that can be worn continuously to provide continuous information to be analyzed as needed by the clinician, that can provide analysis in real-time, that allows for home monitoring of symptoms in subject's with these movement disorders to capture the complex fluctuation patterns of the disease over the course of days, weeks or months, that maximizes subject safety, and that provides remote access to the clinician or physician.
A movement disorder device or system for measuring, quantifying and treating a subject's Parkinson's disease based on a calculated severity of symptoms comprising one or more of tremor;
A movement disorder device or system for measuring, quantifying and treating a subject's Parkinson's disease based on a calculated severity of symptoms comprising one or more of tremor, bradykinesia, rigidity, or dyskinesia, the device or system comprising:
A method of measuring, quantifying and treating a subject's Parkinson's disease based on a calculated severity of symptoms comprising one or more of tremor, bradykinesia, rigidity, or dyskinesia, the method comprising the steps of:
Dependencies are inferred from the claim text.